Jacques Zaneveld’s Post

'Empowering a world-class innovation ecosystem Cambridge is firmly established as a global hub for scientific and technological research, boasting over 5,000 innovation-driven companies, 36 research parks, five hospital trusts, two universities, and a thriving startup and investor community. It was recently named the world’s most intensive science and technological cluster by Global Innovation Index for the third year running. The city’s tech and life sciences companies have raised over $892 million in venture capital funding this year alone, up 38% compared to 2023, according to Dealroom. Quantum company Riverlane’s $75 million round in August significantly contributed to this growth. This means Cambridge could be on track for its best year for VC since 2021, overtaking 2023’s $1.1bn.' Tags: #Cambridgeecosystem, #InnovateCambridge, #innovationecosystem Latest https://lnkd.in/dgMqS3jC

🌐 DeepTech Ventures Summit 2024 by Technoport SA🌐 At the inaugural #DeepTechVentures Summit, Luxembourg’s innovation ecosystem, supported by LIST, among other institutes, showcased its capacity to transform research into #marketready solutions. With strong government support, Luxembourg is cementing its position as a #deeptech hub. 💡 LIST CEO ad interim Dirk Fransaer highlighted the importance of focusing on national research priorities while fostering global collaboration to deliver innovative, applicable solutions. Meet our spinoff companies and discover our high TRL solutions at DeepTech Ventures Demo Day on 20 September including👇 🛰 WASDI - a cloud-based environment for creating, using, and sharing Earth observation-based applications. ⚗ invitrolize - a leader in #invitro testing with its flagship technology, ALIsens®, the only in vitro alveolar model capable of obtaining OECD certification (Arno Gutleb, Sabina Burlă). 💉 ElectroPep - a pioneering #protein screening technology, showcased its innovation in peptide #microarrays, which can provide critical insights into peptide-protein interactions in under a week (Cesar Pascual García) 🏢 TwiSCO - a web application designed to optimize #construction #logistics using Semantic #DigitalTwin Technology and Lean Construction methodology (Fabrice Berroir) 🔬 NANOSENS - a suite of molecular sensing technologies (Sivashankar Krishnamoorthy) Find out more https://lnkd.in/dfcKPhbA

🗣️ “As the UK positions itself as a global tech superpower, start-ups in technology and research-driven sectors can expect to receive stronger support in both funding and talent to enhance growth.” It was brilliant to see Sister’s Academic Innovation Lead Aline Miller featured in Maddyness’ recent article exploring predictions for the innovation landscape in 2025. 🙌 Alongside a stellar line-up of other industry leaders, Aline shared her insights on how start-ups in life sciences, clean energy, biotechnology and AI can expect to benefit from new targeted initiatives and investment opportunities this year, as well as less red tape when taking their ideas to market. She also highlighted the important role that innovation districts play in connecting early-stage companies with the industry expertise and guidance needed for growth. Read the full article here ➡️ https://lnkd.in/eRdbzp73 #Sister #InnovationDistrict #UKStartUps #UKScaleUps #UKInnovation

IBIC Director Aline Miller shares her insights on how start-ups in life sciences, clean energy, biotechnology and AI can expect to benefit from new targeted initiatives and investment opportunities this year, as well as less red tape when taking their ideas to market.

Check out Labiotech.eu’s latest article! Discover everything you need to know about stealth mode biotech startups in the new Labiotech article, “Stealth Mode Biotech Startups: Everything You Need to Know.” In this feature, Natalie Dolphin, our Managing Director, Investor Relations at HLTH Communications, shares her insights on the strategic advantages of operating in stealth mode, from safeguarding intellectual property to refining innovations away from the public eye. 📖 In the article, Natalie explains: “Operating in stealth mode offers biotech startups several strategic advantages, particularly in protecting intellectual property (IP) and allowing focused development away from the prying eyes of competitors.” If you’re curious about how stealth mode can help shape a biotech company’s success and protect its innovations, this is a must-read! 👉 Check out the full article to learn how stealth mode can pave the way for groundbreaking developments and market success. Link in comments!

Is #deeptech a good investment thesis? Well that would be like asking the question, is a app based business a good or bad investment 🚀 - The only answer is it depends. I recently had a coffee ☕ meeting with PreSeed Ventures regarding their new #deeptechfond which will be looking for #earlystage investments. I have on some of my previous posts shared #spinout (university #startup with #ipr based on #research) generally performs better than the counter parts, based on data from DTU - Technical University of Denmark and DTU Skylab . Which means that knowledge based deeptech score higher on most #kpi (expect speed to market) So are these cases #venture cases? My clear answer is #yes in both my conversations with Dr. ir. Ana Koller and Jacob Graves Beck. And here are my reflections on why. DTU is a relatively small university on a global scale with explicit emphasis on #entrepreneurship that is less than a decade old set in motion by Anders Overgaard Bjarklev, Marianne Thellersen and Mikkel Sørensen. In spite of this short experience and size, we still produce #unicorns like 3Shape and NKT Photonics. And some companies that could have reached these heights earlier with better capital infrastructure. But we also have the next generation of companies claiming the growth 📈 hills to become unicorns who will it be? Eupry Reshape Biotech NIL Technology Norlase MASH Makes So statistically, then there is a higher frequency of unicorns among deeptech and they have a higher likelihood of reaching higher valuations with reduced risks other than time 🤔 This leaves me with the question, are we or have we become a unicorn factory or is it in our DNA 🧬 to fight the odds?

Are you an entrepreneur or researcher looking to transform your groundbreaking biotech ideas into reality? The journey from concept to market can be overwhelming, especially without the right resources and support. Many startups struggle to find suitable lab facilities that foster innovation and collaboration while providing the necessary infrastructure to execute their projects effectively. Don’t let your innovative ideas stay on the drawing board! Kickstart your biotech innovation journey with CUBIO—visit our website to schedule a tour of our facilities and discover how we can help you turn your ideas into reality. The future of biotech begins here!

🔬 𝐂𝐨-𝐖𝐨𝐫𝐤𝐢𝐧𝐠 𝐋𝐚𝐛𝐬: 𝐓𝐡𝐞 𝐈𝐝𝐞𝐚𝐥 𝐋𝐚𝐮𝐧𝐜𝐡𝐩𝐚𝐝 𝐟𝐨𝐫 𝐘𝐨𝐮𝐫 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐕𝐞𝐧𝐭𝐮𝐫𝐞? 🔬 Discover how co-working labs provide the ideal environment for biotech start-ups to thrive and innovate. 👥 𝐈𝐦𝐚𝐠𝐢𝐧𝐞 𝐥𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐲𝐨𝐮𝐫 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭-𝐮𝐩 with minimal overhead and maximum support. That’s the magic of co-working labs! These innovative spaces are transforming the biotech landscape by slashing costs and accelerating progress for new ventures. 🌟 𝐖𝐡𝐲 𝐂𝐨-𝐖𝐨𝐫𝐤𝐢𝐧𝐠 𝐋𝐚𝐛𝐬 𝐀𝐫𝐞 𝐚 𝐆𝐚𝐦𝐞-𝐂𝐡𝐚𝐧𝐠𝐞𝐫: Shared lab spaces offer more than just equipment; they provide a vibrant community and access to invaluable mentorship. From reducing start-up costs to enhancing creative collisions, these labs are designed to help you thrive. 💡 𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬: 💵 𝐂𝐨𝐬𝐭 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲:  Save by renting equipped lab spaces rather than building your own. 🤝 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐯𝐞 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲: Engage with peers who are navigating similar challenges and celebrate collective successes. 🔄 𝐅𝐥𝐞𝐱𝐢𝐛𝐢𝐥𝐢𝐭𝐲: Adapt your space and resources as your start-up grows. 🌍 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐈𝐦𝐩𝐚𝐜𝐭: At Bastion Therapeutics, we found the perfect home at the Imperial White City Incubator, a co-working lab that’s fuelling our innovation and growth. Start-ups like ours are thriving in these dynamic environments, leveraging shared resources and expertise to push their innovations forward. 🔮 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐀𝐡𝐞𝐚𝐝: The rise of co-working labs signals a shift towards more collaborative and cost-effective solutions in the biotech industry. As more companies join this trend, expect to see even greater advances in science and technology! #Biotech #Innovation #Startups

🗓️ Upcoming Event: The Cornell Research & Innovation workshop is happening on September 12—A Scientist’s Dilemma: Am I the CEO or CTO? This free workshop is tailored for researchers interested in pursuing the commercialization of their innovative technologies, focusing on the roles that startup founders with scientific backgrounds can assume in their ventures. 🔗 https://ow.ly/GVZr50Thj69

Action Tank 2024: Exploring biotech through innovation, collaboration, and policy Thanks to the Butler Institute, I had a unique opportunity to deep dive into the biotech industry from all angles: startups, big pharma, policymakers, and civil society. 🏢 One highlight was visiting Pfizer and Lab Central in Cambridge, where we witnessed firsthand the ecosystems driving biotech innovation. Here are three quick points from this experience: 1️⃣ LabCentral's ecosystem model accelerates innovation: From shared labs to mentoring programs like CEO roundtables, LabCentral provides the infrastructure, expertise, and network startups need to thrive from day one. It’s inspiring to see how their ecosystem supports life-changing discoveries as well and it is clear the importance of frequently having different stakeholders interacting. 2️⃣ Biotech startups test faster but face unique cycles: Unlike casual tech startups, biotech ventures must navigate complex, longer timelines due to rigorous clinical trials and regulatory demands. 3️⃣ Policy as both opportunity and challenge: Adapting to regulations can unlock growth, but requires strategic creativity (example: Mass Leads Act to bring $$$ to Climatetech, Life Sciences, and AI). The biotech industry in Massachusetts is thriving, with $7.9 billion in venture capital raised in 2024 and +117k jobs. The region remains a global biotech powerhouse, driving innovation and economic growth through high-profile investments, mergers, and startups shaping the future of healthcare. Thank the Babson students and facilitators who made this experience unique. Also, I want to leave a special thank you note to Clare Currie and Cindy Klein Marmer, who organized the event with excellence and care. Thank you for creating such a transformative experience! 🤘 #Biotech #Entrepreneurship #BabsonCollege #ActionTank